A detailed history of Rothschild Investment LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 35 shares of HRMY stock, worth $1,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 15 133.33%
Holding current value
$1,221
Previous $453,000 209.05%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$30.0 - $39.95 $600 - $799
20 Added 133.33%
35 $1.4 Million
Q2 2024

Jul 30, 2024

BUY
$28.81 - $33.01 $432 - $495
15 New
15 $453,000
Q1 2024

Jul 31, 2024

SELL
$29.93 - $35.06 $299 - $350
-10 Reduced 66.67%
5 $168,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.07B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.